Fatal varicella pneumonia in an unvaccinated child with Down Syndrome: a case report by unknown
CASE REPORT Open Access
Fatal varicella pneumonia in an
unvaccinated child with Down
Syndrome: a case report
Diletta Valentini1*, Simona Bianchi1, Chiara Di Camillo1, Anna Chiara Vittucci1, Michaela Veronika Gonfiantini1,
Rita De Vito2 and Alberto Villani1
Abstract
Background: Varicella is an acute infectious disease common during childhood. It has mostly an uncomplicated
course in early childhood. Neverthless, it may result in severe complications, especially in particular age groups and
clinical conditions. Down Syndrome represents a risk factor for developing complications, because of the frequent
comorbidities and their immunodeficiency.
Case presentation: A 2-year-old white Caucasian female affected by Down Syndrome was referred to our hospital
for cardiac arrest in course of varicella disease. After cardiopulmonary resuscitation and stabilization, her clinical
conditions didn’t improve and she developed a massive pulmonary hemorrage, which led her to exitus.
Conclusions: Mortality due to varicella infection is rare, but it is more common in subjects with immune deficit or
chronic pathologies, and in particular age-groups. The importance of the vaccine for preventable infectious diseases
is stressed in this paper, in which we present a case of death in an unvaccinated cardiopathic child with Down
Syndrome affected by varicella.
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Background
Varicella is an acute, exanthematous, highly infectious dis-
ease, that most commonly occurs in childhood. Varicella
normally has a benign course, but can occasionally de-
velop into a more serious illness, especially in adults,
immunodeficient children, pregnant women, newborn
babies [1]. A lethal outcome is very rare, with a mortal-
ity rate fluctuating between 0.29 and 0.46 deaths per 1
million. The introduction of the vaccine in 1995 has
substantially decreased varicella incidence, hospitaliza-
tions, and deaths [2].
The most common complications of varicella are
bacterial skin infection, sepsis, pneumonia, and central
nervous system events such as cerebellar ataxia and
encephalitis [3, 4].
Case presentation
A 2-years-old white Caucasian female affected by Down
Syndrome (DS) and surgically corrected at 3 months of
age for a subaortic intraventricular defect (IVD), with a
history of 2 episodes of pneumonia, was admitted in
the emergency room of our hospital due to a cardiac ar-
rest during her varicella illness. She had never been
vaccinated up to the moment, that’s why she contracted
the disease from her sister. The night before her admis-
sion to the hospital, she began to manifest episodes of
hypotonia associated to periods of crying. At 4 o’clock
she began to show signs of a generalized hypotonia and
she was taken to our hospital by her parents, where she
arrived in cardiac arrest. After Cardio-Pulmonary Re-
suscitation (CPR-PALS) her spontaneous breathing was
restored. The clinical course was characterized by
complete areflexia, with bilateral mydriasis. Breathing
pattern was characterized by ARDS that required high
frequency mechanical ventilation and Nitric Oxide with
transient improvement.
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We proceeded to perform a chest X-ray (CXR), which
revealed multiple foci of parenchymal spread to both
lungs and pleural effusion obliterating share of the
breast-phrenic cost (Fig. 1). An abdominal ultrasound
showed the presence of abdominal effusion in all quad-
rants and laboratory tests revealed the presence of IgM
antibodies against varicella, positive PCR for varicella
antigen, absence of bacterial infections (coltures of blood
and urine), prolonged PT and PTT, and altered D-Dimer.
Tests for immunological functions were performed
(Table 1).
The next day, the respiratory condition didn’t improve
and a new CXR showed an impairment of the spread,
and a massive pulmonary hemorrhage. In the absence of
recovery of the main indicators of organ perfusion, she
was declared dead.
At macroscopic examination the lungs were heavy,
firm and plum-colored, with diffuse areas of hemorrhage
and necrosis.
Histologically there are interstitial pneumonitis, diffuse
necrosis and hemorrhage in the pulmonary parenchyma
(Fig. 2).
Conclusions
The estimated global burden of disease-specific mortality
caused by varicella is considerably lower than that due to
other major infectious diseases such as measles, pertussis,
rotavirus, or invasive pneumococcal disease. Based on
conservative estimates, the global annual varicella disease
burden reports 4.2 million severe complications leading to
hospitalization and 4200 deaths [5].
The prevalence of immunocompromising conditions
including HIV infection and the kind of treatment
available, are factors which influence the course of the
disease. In healthy children, varicella is usually self-
limiting and benign [6].
Groups at higher risk for severe complications are: ne-
onates, infants, pregnant women, adults, and immuno-
compromised patients.
The type of varicella complications depends on the pa-
tient’s age. A study of Gowin et al. demonstrates that the
average age of varicella-complications in hospitalized
children is 3.12 years [7, 8]. The youngest children had
pneumonia, and the oldest meningitis/meningoencephalitis
[9, 10].
Older children considered to be more susceptible to
antibody-mediated inflammatory reactions, whereas youn-
ger, less immunocompetent patients are more frequently
affected by bacterial suprainfections of the skin or of the
respiratory tract [11, 12].
Respiratory tract infections were present in younger
children, and usually developed at the beginning of the
varicella infection [7]. The high frequency of respiratory
tract complications reflects the biology of the virus. The
virus enters the host through the respiratory tract and
then spreads in the bloodstream. A cytopathic effect of
Fig. 1 Chest X-Ray: multiple foci of parenchymal spread to both lungs and pleural effusion obliterating share of the breast-phrenic cost
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the varicella virus on the alveolar epithelium causes
pneumonia. Desquamated alveolar cells contribute to
reduce gas exchange.
Hematological complications are observed in 1–2% of
children with varicella. Patients usually remain asymptom-
atic. Like many other thrombocytopenias and anemias
during viral infections, those in patients with varicella are
transient and require no treatment. Laboratory tests are
not performed routinely in patients with varicella [13].
Our case suffered from acute respiratory distress syn-
drome (ARDS) caused by varicella, and associated to
hematological disorders that provoked the development
of pulmonary hemorrhage, which caused death.
Children who are diagnosed with Down syndrome and
who have comorbidities such as immunodeficiency or car-
diopathy have high rates of viral and bacterial infections
such as influenza and pneumococcal infections [14]. The
most common symptoms reported in children with DS
are infections of the respiratory tract suggesting a B-cell
defect [15]. Diseases related to T-cell deficiency, such as
infection with intra-cellular microorganism, fungi and op-
portunistic pathogens are rare [16].
Varicella is one of the most infective disease that affects
the pediatric population.
Guidelines stress the importance of an anti-varicella
vaccination for all children older than 12 months as
well as children with DS [17]. The only contraindica-
tion of the vaccine is severe immunodeficiency of the T
cells [6]. Despite the fact that most children hospital-
ized with varicella complications were immunologically
healthy, risks are superior in subjects with chronic
conditions [6, 18].
Children with DS have a higher risk of being hospital-
ized for viral respiractory tract infections, even in the ab-
sence of coexisting risk factors [19], and the mortality rate
in severe ill DS children admitted for medical reasons is
high and is predominantly associated with respiratory
conditions [20]. As the burden of preventable infections in
children diagnosed with chronic diseases is high in terms
Table 1 Blood investigations performed at the emergency
room access
Investigation Value Reference value
White bllod cells 15.65 (*103/uL) 5.5–15
Red blood cells 4.03 (*106/*uL) 3.6–5
Hemoglobin 9 (g/dL) 10.5–15.5
Platelets 131 (103/uL) 150–450
PTT-s 50.5 (seconds) 25–34
PTT-r 1.73 (seconds) 0.85–1.15
Trombin Time 27.6 (seconds) 16–22
Antitrombine III 34 (%) 75–120
Fibrinogen Dimeri 6.7 (microg/mL) <0.5
LDH 4150 (UI/L) 230–470
CPK 3595 (UI/L) 32–211
CD3-pan T 56.4 (%) 58–75
CD4 T Helper 16.8 (%) 29–47
CD8 T Suppressor/Cytotoxic 39.7 (%) 17–33
CD19 Pan B 36 (%) 14–30
CD16 + CD56+ 6.7 (%) 4–17
VZV PCR positive Negative
VZV IgG negative –
VZV IgM positive –
Fig. 2 Histological image that showed interstitial pneumonitis and diffuse necrosis and hemorrhage in the pulmonary parenchyma
Valentini et al. Italian Journal of Pediatrics  (2016) 42:99 Page 3 of 4
of incidence and severity, it is essential to protect these
children with timely administration of vaccinations ac-
cording to the current recommendations.
Even among populations at risk, varicella vaccine is the
less used. Although Italian Down children have the best
vaccination coverage among all patients with chronic
disease [21], it is clear that it is desirable to improve
vaccination coverage among risk groups and also among
the healthy population.
Implemented interventions, with special reminders to
parents and general practitioners, are necessary to promote
timely vaccination in DS children who are susceptible to
preventable infections and prone to severe complications.
This case underlines how varicella may lead to severe,
potentially life-threatening complications in unvaccinated
children and adolescents, and may demonstrate too the
benefits of varicella vaccination.
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